AKBA
Akebia Therapeutics, Inc. · Healthcare
SVP and COO Michel Dahan sold $44K of Akebia Therapeutics, Inc.
Sold$43,898
$1.26Price
34,840Shares
−5%Stake
What AKBA did after the filing
- The stock from Tue, May 14 close, $1.23
- −19.6%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Jun 27 close.
Traded Mon, May 13. Filed Tue, May 14, 12:04 PM ET, during the session. Returns use the May 14 close and the Jun 27 close. Not investment advice.